Literature DB >> 12058646

Transmission-blocking vaccines.

David C Kaslow1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12058646     DOI: 10.1159/000058850

Source DB:  PubMed          Journal:  Chem Immunol        ISSN: 0079-6034


× No keyword cloud information.
  34 in total

1.  Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.

Authors:  Masanori Doi; Kazuyuki Tanabe; Shin-Ichiro Tachibana; Meiko Hamai; Mayumi Tachibana; Toshihiro Mita; Masanori Yagi; Fadile Yildiz Zeyrek; Marcelo U Ferreira; Hiroshi Ohmae; Akira Kaneko; Milijaona Randrianarivelojosia; Jetsumon Sattabongkot; Ya-Ming Cao; Toshihiro Horii; Motomi Torii; Takafumi Tsuboi
Journal:  Vaccine       Date:  2011-04-21       Impact factor: 3.641

Review 2.  Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.

Authors:  Ajay K Saxena; Yimin Wu; David N Garboczi
Journal:  Eukaryot Cell       Date:  2007-06-08

3.  Formulation of vaccines containing CpG oligonucleotides and alum.

Authors:  Joan A Aebig; Gregory E D Mullen; Gelu Dobrescu; Kelly Rausch; Lynn Lambert; Olubunmi Ajose-Popoola; Carole A Long; Allan Saul; Aaron P Miles
Journal:  J Immunol Methods       Date:  2007-05-11       Impact factor: 2.303

Review 4.  Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines.

Authors:  Godfree Mlambo; Nirbhay Kumar
Journal:  Eukaryot Cell       Date:  2008-09-19

5.  Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon.

Authors:  Sonali Kochhar
Journal:  Hum Vaccin Immunother       Date:  2013-01-15       Impact factor: 3.452

6.  Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.

Authors:  Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

7.  Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.

Authors:  Rajesh Kumar; Ruth Nyakundi; Thomas Kariuki; Hastings Ozwara; Onkoba Nyamongo; Godfree Mlambo; Barry Ellefsen; Drew Hannaman; Nirbhay Kumar
Journal:  Vaccine       Date:  2013-05-16       Impact factor: 3.641

8.  Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.

Authors:  Rajesh Kumar; Evelina Angov; Nirbhay Kumar
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

9.  Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice.

Authors:  Nikolay S Outchkourov; Will Roeffen; Anita Kaan; Josephine Jansen; Adrian Luty; Danielle Schuiffel; Geert Jan van Gemert; Marga van de Vegte-Bolmer; Robert W Sauerwein; Hendrik G Stunnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

10.  A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.

Authors:  Debabani Roy Chowdhury; Evelina Angov; Thomas Kariuki; Nirbhay Kumar
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.